CSI Market
Sign In | Register

Ascendis Pharma A (ASND) Annual Balance Sheets

Annual · GAAP · USD millions
Access ASND quarterly Balance Sheets →
A period-by-period view of the balance sheet from Ascendis Pharma A to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents722.99
Current Tax Assets Current1.99
Cash & Short-term Investments723.00
Accounts receivable165.87
Inventories2.09
Inventories353.88
Other Current Assets54.09
Total Current Assets1,301.50
Equipment/Property/Plant Net171.91
Intangible AssetsAnd Goodwill4.16
Other Current Receivables16.33
Current Prepayments37.76
Investments In Associates36.43
Other Noncurrent Receivables12.17
Marketable Securities Non Current Assets216.82
Noncurrent Assets0.00
Total Assets1,528.70
Liabilities
Current Tax Liabilities7.54
Short-term Debt452.13
Other Liabilities, Current572.67
Current Provisions195.28
Total Current Liabilities1,255.04
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI11.29
Other liabilities, Noncurrent432.74
Other Current Financial Liabilities429.82
Noncurrent Contract Liabilities1.26
Noncurrent Liabilities443.52
Current Lease Liabilities0.00
Current Contract Liabilities5.54
Trade And Other Current Payables To Trade Suppliers101.54
Other Current Liabilities65.19
Total Liabilities1,719.78
Stockholders' Equity
Noncurrent Lease Liabilities-
Other Equity-182.36
Common Stockholder's Equity-182.36
Total Stockholder's Equity-182.36
Liabilities & Stockholder's Equity1,528.70
4 historic quarters locked

Sign in to unlock the full Ascendis Pharma A balance sheet history.

Sign In Create Free Account

About Ascendis Pharma A s Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 11, 2026
  • Source: asnd-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-046590

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License